Company page
Metagenomi Therapeutics, Inc.
Metagenomi Therapeutics, Inc. is a public company traded under the ticker MGX in the American market. The company has a market capitalization of approximately $45.36 million. Metagenomi focuses on developing innovative gene editing technologies to advance therapeutic solutions.
- Ticker
- MGX:NASDAQ
- Asset type
- Stock
- Market cap
- $45.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD